Assembly Bio announces closing of offering of $165.6 common stock and underwriters’ option
Assembly Biosciences announced the closing of an underwritten public offering of 4,600,000 shares of its common stock to the public at $36.00 per share, which included the exercise in full by the underwriters of their option to purchase 600,000 additional shares of common stock. July 16, 2018